St George's, University of London, is a University located in Tooting in South London and is a constituent college of the University of London. St George's has its origins in 1733, and was the second institution in England to provide formal training courses for doctors.

During the past decade, St. George's University of London conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 7 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 4 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. George's University of London" #1 sponsor was "St George's, University of London" with 23 trials, followed by "Lymphoma Trials Office" with 3 trials sponsored, "Altimmune, Inc." with 2 trials sponsored, "European Society for Blood and Marrow Transplantation" with 2 trials sponsored and "University College, London" with 2 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 30 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. George's University of London" #1 collaborator was "Lymphoma Trials Office" with 2 trials as a collaborator, "Neurosciences Research Foundation" with 2 trials as a collaborator, "Public Health England" with 2 trials as a collaborator, "St George's, University of London" with 2 trials as a collaborator and "University College, London" with 2 trials as a collaborator. Other collaborators include 34 different institutions and companies that were collaborators in the rest 43 trials.

According to Clinical.Site data, the most researched conditions in "St. George's University of London" are "Lymphoma" (5 trials), "Hypertension" (3 trials), "Atrial Fibrillation" (2 trials), "Breast Cancer" (2 trials) and "Group B Streptococcus" (2 trials). Many other conditions were trialed in "St. George's University of London" in a lesser frequency.

Most popular intervention types in "St. George's University of London" are "Drug" (26 trials), "Biological" (13 trials), "Procedure" (13 trials), "Other" (10 trials) and "Behavioral" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "cyclophosphamide" (5 trials), "etoposide" (3 trials), "rituximab" (3 trials) and "vincristine sulfate" (3 trials). Other intervention names were less common.

The vast majority of trials in "St. George's University of London" are 45 trials for "All" genders and 12 trials for "Female" genders.

Currently, there are NaN active trials in "St. George's University of London". 2 are not yet recruiting, 10 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 30 completed trials in St. George's University of London, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in St. George's University of London, 8 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".

St. George's University of London has several departments that took part in Clinical trials: "Blood Pressure Unit, Dept. Cardiac & Vascular Sciences, SGUL" - 2 trials